A detailed history of Arizona State Retirement System transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Arizona State Retirement System holds 12,805 shares of PTGX stock, worth $496,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,805
Previous 12,666 1.1%
Holding current value
$496,193
Previous $569,000 13.18%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$38.51 - $48.43 $5,352 - $6,731
139 Added 1.1%
12,805 $494,000
Q3 2024

Nov 12, 2024

BUY
$33.72 - $47.33 $14,499 - $20,351
430 Added 3.51%
12,666 $569,000
Q2 2024

Aug 05, 2024

SELL
$24.66 - $34.8 $10,973 - $15,485
-445 Reduced 3.51%
12,236 $423,000
Q1 2024

May 07, 2024

SELL
$21.79 - $32.15 $4,031 - $5,947
-185 Reduced 1.44%
12,681 $366,000
Q4 2023

Jan 24, 2024

SELL
$14.05 - $23.44 $2,458 - $4,102
-175 Reduced 1.34%
12,866 $295,000
Q3 2023

Nov 06, 2023

BUY
$16.68 - $23.66 $6,605 - $9,369
396 Added 3.13%
13,041 $217,000
Q2 2023

Aug 01, 2023

BUY
$18.02 - $29.36 $35,211 - $57,369
1,954 Added 18.28%
12,645 $349,000
Q1 2023

Apr 27, 2023

BUY
$10.78 - $25.38 $3,277 - $7,715
304 Added 2.93%
10,691 $245,000
Q4 2022

Feb 07, 2023

BUY
$7.36 - $11.17 $76,448 - $116,022
10,387 New
10,387 $113,000
Q2 2022

Jul 28, 2022

SELL
$7.06 - $25.52 $81,980 - $296,338
-11,612 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$23.34 - $36.08 $2,193 - $3,391
94 Added 0.82%
11,612 $275,000
Q4 2021

Feb 04, 2022

BUY
$17.63 - $37.1 $13,134 - $27,639
745 Added 6.92%
11,518 $394,000
Q3 2021

Nov 12, 2021

BUY
$12.95 - $49.69 $958 - $3,677
74 Added 0.69%
10,773 $191,000
Q2 2021

Aug 02, 2021

BUY
$25.57 - $44.88 $1,406 - $2,468
55 Added 0.52%
10,699 $480,000
Q1 2021

May 06, 2021

BUY
$19.02 - $31.15 $202,448 - $331,560
10,644 New
10,644 $276,000

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.9B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.